GLENMEDE TRUST CO NA
BankPosition in TEVA — Teva Pharmaceutical Industries Ltd
CIK 314949
PHILADELPHIA, PA
Position in TEVA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,849,339
+$241,624 QoQ
Shares Held
54,585
+2.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#277
of 671 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $58,285,011 across 15 Drug Manufacturers - Specialty & Generic names. TEVA ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
361,184 | $18,926,041 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
210,952 | $9,811,377 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
205,818 | $9,729,016 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
13,521 | $7,326,082 | |
| 5 | ZTS |
Zoetis Inc.
|
86,974 | $6,249,950 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
54,585 | $1,849,339 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
69,836 | $1,718,663 | |
| 8 | HLN |
Haleon plc
|
63,613 | $593,509 |
All Filings in TEVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,849,339 | 54,585 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,607,715 | 53,377 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $284,135 | 9,104 | Shares | Sole | 2026-02-17 | |
| 2020-09-30 | $19,145 | 2,125 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $25,695 | 2,084 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $22,503 | 2,506 | Shares | Defined | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||